img

Global Consumer Healthcare Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Consumer Healthcare Drug Market Research Report 2024

Consumer health products are products sold directly to consumers. Unlike prescription drugs, selection and use of consumer health products does not require the oversight of a health care practitioner.
According to Mr Accuracy reports’s new survey, global Consumer Healthcare Drug market is projected to reach US$ 182520 million in 2029, increasing from US$ 125150 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Consumer Healthcare Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Consumer Healthcare Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johnson & Johnson
AbbVie
Merck & Co.
GlaxoSmithKline
Pfizer
Sanofi
Takeda
Bayer
Teva
Sinopharm Group
CR Pharmaceutical
Shanghai Pharmaceuticals
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
Fosun Pharma
East China Medicine
Livzon Group
Segment by Type
Solid Preparations
Oral Liquid
Patch
Other

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Consumer Healthcare Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Consumer Healthcare Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Solid Preparations
1.2.3 Oral Liquid
1.2.4 Patch
1.2.5 Other
1.3 Market by Application
1.3.1 Global Consumer Healthcare Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Consumer Healthcare Drug Market Perspective (2018-2029)
2.2 Consumer Healthcare Drug Growth Trends by Region
2.2.1 Global Consumer Healthcare Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Consumer Healthcare Drug Historic Market Size by Region (2018-2024)
2.2.3 Consumer Healthcare Drug Forecasted Market Size by Region (2024-2029)
2.3 Consumer Healthcare Drug Market Dynamics
2.3.1 Consumer Healthcare Drug Industry Trends
2.3.2 Consumer Healthcare Drug Market Drivers
2.3.3 Consumer Healthcare Drug Market Challenges
2.3.4 Consumer Healthcare Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Consumer Healthcare Drug Players by Revenue
3.1.1 Global Top Consumer Healthcare Drug Players by Revenue (2018-2024)
3.1.2 Global Consumer Healthcare Drug Revenue Market Share by Players (2018-2024)
3.2 Global Consumer Healthcare Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Consumer Healthcare Drug Revenue
3.4 Global Consumer Healthcare Drug Market Concentration Ratio
3.4.1 Global Consumer Healthcare Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Consumer Healthcare Drug Revenue in 2022
3.5 Consumer Healthcare Drug Key Players Head office and Area Served
3.6 Key Players Consumer Healthcare Drug Product Solution and Service
3.7 Date of Enter into Consumer Healthcare Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Consumer Healthcare Drug Breakdown Data by Type
4.1 Global Consumer Healthcare Drug Historic Market Size by Type (2018-2024)
4.2 Global Consumer Healthcare Drug Forecasted Market Size by Type (2024-2029)
5 Consumer Healthcare Drug Breakdown Data by Application
5.1 Global Consumer Healthcare Drug Historic Market Size by Application (2018-2024)
5.2 Global Consumer Healthcare Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Consumer Healthcare Drug Market Size (2018-2029)
6.2 North America Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Consumer Healthcare Drug Market Size by Country (2018-2024)
6.4 North America Consumer Healthcare Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Consumer Healthcare Drug Market Size (2018-2029)
7.2 Europe Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Consumer Healthcare Drug Market Size by Country (2018-2024)
7.4 Europe Consumer Healthcare Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Consumer Healthcare Drug Market Size (2018-2029)
8.2 Asia-Pacific Consumer Healthcare Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Consumer Healthcare Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Consumer Healthcare Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Consumer Healthcare Drug Market Size (2018-2029)
9.2 Latin America Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Consumer Healthcare Drug Market Size by Country (2018-2024)
9.4 Latin America Consumer Healthcare Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Consumer Healthcare Drug Market Size (2018-2029)
10.2 Middle East & Africa Consumer Healthcare Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Consumer Healthcare Drug Introduction
11.1.4 Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2018-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Consumer Healthcare Drug Introduction
11.2.4 AbbVie Revenue in Consumer Healthcare Drug Business (2018-2024)
11.2.5 AbbVie Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Detail
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Consumer Healthcare Drug Introduction
11.3.4 Merck & Co. Revenue in Consumer Healthcare Drug Business (2018-2024)
11.3.5 Merck & Co. Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Consumer Healthcare Drug Introduction
11.4.4 GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2018-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Consumer Healthcare Drug Introduction
11.5.4 Pfizer Revenue in Consumer Healthcare Drug Business (2018-2024)
11.5.5 Pfizer Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Consumer Healthcare Drug Introduction
11.6.4 Sanofi Revenue in Consumer Healthcare Drug Business (2018-2024)
11.6.5 Sanofi Recent Development
11.7 Takeda
11.7.1 Takeda Company Detail
11.7.2 Takeda Business Overview
11.7.3 Takeda Consumer Healthcare Drug Introduction
11.7.4 Takeda Revenue in Consumer Healthcare Drug Business (2018-2024)
11.7.5 Takeda Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Consumer Healthcare Drug Introduction
11.8.4 Bayer Revenue in Consumer Healthcare Drug Business (2018-2024)
11.8.5 Bayer Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Consumer Healthcare Drug Introduction
11.9.4 Teva Revenue in Consumer Healthcare Drug Business (2018-2024)
11.9.5 Teva Recent Development
11.10 Sinopharm Group
11.10.1 Sinopharm Group Company Detail
11.10.2 Sinopharm Group Business Overview
11.10.3 Sinopharm Group Consumer Healthcare Drug Introduction
11.10.4 Sinopharm Group Revenue in Consumer Healthcare Drug Business (2018-2024)
11.10.5 Sinopharm Group Recent Development
11.11 CR Pharmaceutical
11.11.1 CR Pharmaceutical Company Detail
11.11.2 CR Pharmaceutical Business Overview
11.11.3 CR Pharmaceutical Consumer Healthcare Drug Introduction
11.11.4 CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2024)
11.11.5 CR Pharmaceutical Recent Development
11.12 Shanghai Pharmaceuticals
11.12.1 Shanghai Pharmaceuticals Company Detail
11.12.2 Shanghai Pharmaceuticals Business Overview
11.12.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Introduction
11.12.4 Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2018-2024)
11.12.5 Shanghai Pharmaceuticals Recent Development
11.13 Hualan Bio
11.13.1 Hualan Bio Company Detail
11.13.2 Hualan Bio Business Overview
11.13.3 Hualan Bio Consumer Healthcare Drug Introduction
11.13.4 Hualan Bio Revenue in Consumer Healthcare Drug Business (2018-2024)
11.13.5 Hualan Bio Recent Development
11.14 North China Pharmaceutical
11.14.1 North China Pharmaceutical Company Detail
11.14.2 North China Pharmaceutical Business Overview
11.14.3 North China Pharmaceutical Consumer Healthcare Drug Introduction
11.14.4 North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2024)
11.14.5 North China Pharmaceutical Recent Development
11.15 Hengrui Medicine
11.15.1 Hengrui Medicine Company Detail
11.15.2 Hengrui Medicine Business Overview
11.15.3 Hengrui Medicine Consumer Healthcare Drug Introduction
11.15.4 Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2018-2024)
11.15.5 Hengrui Medicine Recent Development
11.16 Fosun Pharma
11.16.1 Fosun Pharma Company Detail
11.16.2 Fosun Pharma Business Overview
11.16.3 Fosun Pharma Consumer Healthcare Drug Introduction
11.16.4 Fosun Pharma Revenue in Consumer Healthcare Drug Business (2018-2024)
11.16.5 Fosun Pharma Recent Development
11.17 East China Medicine
11.17.1 East China Medicine Company Detail
11.17.2 East China Medicine Business Overview
11.17.3 East China Medicine Consumer Healthcare Drug Introduction
11.17.4 East China Medicine Revenue in Consumer Healthcare Drug Business (2018-2024)
11.17.5 East China Medicine Recent Development
11.18 Livzon Group
11.18.1 Livzon Group Company Detail
11.18.2 Livzon Group Business Overview
11.18.3 Livzon Group Consumer Healthcare Drug Introduction
11.18.4 Livzon Group Revenue in Consumer Healthcare Drug Business (2018-2024)
11.18.5 Livzon Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Consumer Healthcare Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Solid Preparations
Table 3. Key Players of Oral Liquid
Table 4. Key Players of Patch
Table 5. Key Players of Other
Table 6. Global Consumer Healthcare Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Consumer Healthcare Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Consumer Healthcare Drug Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Consumer Healthcare Drug Market Share by Region (2018-2024)
Table 10. Global Consumer Healthcare Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Consumer Healthcare Drug Market Share by Region (2024-2029)
Table 12. Consumer Healthcare Drug Market Trends
Table 13. Consumer Healthcare Drug Market Drivers
Table 14. Consumer Healthcare Drug Market Challenges
Table 15. Consumer Healthcare Drug Market Restraints
Table 16. Global Consumer Healthcare Drug Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Consumer Healthcare Drug Market Share by Players (2018-2024)
Table 18. Global Top Consumer Healthcare Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Consumer Healthcare Drug as of 2022)
Table 19. Ranking of Global Top Consumer Healthcare Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Consumer Healthcare Drug Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Consumer Healthcare Drug Product Solution and Service
Table 23. Date of Enter into Consumer Healthcare Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Consumer Healthcare Drug Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Consumer Healthcare Drug Revenue Market Share by Type (2018-2024)
Table 27. Global Consumer Healthcare Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Consumer Healthcare Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Consumer Healthcare Drug Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Consumer Healthcare Drug Revenue Market Share by Application (2018-2024)
Table 31. Global Consumer Healthcare Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Consumer Healthcare Drug Revenue Market Share by Application (2024-2029)
Table 33. North America Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Consumer Healthcare Drug Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Consumer Healthcare Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Consumer Healthcare Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Consumer Healthcare Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Consumer Healthcare Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Consumer Healthcare Drug Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Consumer Healthcare Drug Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Consumer Healthcare Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Consumer Healthcare Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Consumer Healthcare Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Consumer Healthcare Drug Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Consumer Healthcare Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. Johnson & Johnson Company Detail
Table 49. Johnson & Johnson Business Overview
Table 50. Johnson & Johnson Consumer Healthcare Drug Product
Table 51. Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 52. Johnson & Johnson Recent Development
Table 53. AbbVie Company Detail
Table 54. AbbVie Business Overview
Table 55. AbbVie Consumer Healthcare Drug Product
Table 56. AbbVie Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 57. AbbVie Recent Development
Table 58. Merck & Co. Company Detail
Table 59. Merck & Co. Business Overview
Table 60. Merck & Co. Consumer Healthcare Drug Product
Table 61. Merck & Co. Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 62. Merck & Co. Recent Development
Table 63. GlaxoSmithKline Company Detail
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Consumer Healthcare Drug Product
Table 66. GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Consumer Healthcare Drug Product
Table 71. Pfizer Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Sanofi Company Detail
Table 74. Sanofi Business Overview
Table 75. Sanofi Consumer Healthcare Drug Product
Table 76. Sanofi Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Takeda Company Detail
Table 79. Takeda Business Overview
Table 80. Takeda Consumer Healthcare Drug Product
Table 81. Takeda Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 82. Takeda Recent Development
Table 83. Bayer Company Detail
Table 84. Bayer Business Overview
Table 85. Bayer Consumer Healthcare Drug Product
Table 86. Bayer Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Teva Company Detail
Table 89. Teva Business Overview
Table 90. Teva Consumer Healthcare Drug Product
Table 91. Teva Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 92. Teva Recent Development
Table 93. Sinopharm Group Company Detail
Table 94. Sinopharm Group Business Overview
Table 95. Sinopharm Group Consumer Healthcare Drug Product
Table 96. Sinopharm Group Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 97. Sinopharm Group Recent Development
Table 98. CR Pharmaceutical Company Detail
Table 99. CR Pharmaceutical Business Overview
Table 100. CR Pharmaceutical Consumer Healthcare Drug Product
Table 101. CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 102. CR Pharmaceutical Recent Development
Table 103. Shanghai Pharmaceuticals Company Detail
Table 104. Shanghai Pharmaceuticals Business Overview
Table 105. Shanghai Pharmaceuticals Consumer Healthcare Drug Product
Table 106. Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 107. Shanghai Pharmaceuticals Recent Development
Table 108. Hualan Bio Company Detail
Table 109. Hualan Bio Business Overview
Table 110. Hualan Bio Consumer Healthcare Drug Product
Table 111. Hualan Bio Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 112. Hualan Bio Recent Development
Table 113. North China Pharmaceutical Company Detail
Table 114. North China Pharmaceutical Business Overview
Table 115. North China Pharmaceutical Consumer Healthcare Drug Product
Table 116. North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 117. North China Pharmaceutical Recent Development
Table 118. Hengrui Medicine Company Detail
Table 119. Hengrui Medicine Business Overview
Table 120. Hengrui Medicine Consumer Healthcare Drug Product
Table 121. Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 122. Hengrui Medicine Recent Development
Table 123. Fosun Pharma Company Detail
Table 124. Fosun Pharma Business Overview
Table 125. Fosun Pharma Consumer Healthcare Drug Product
Table 126. Fosun Pharma Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 127. Fosun Pharma Recent Development
Table 128. East China Medicine Company Detail
Table 129. East China Medicine Business Overview
Table 130. East China Medicine Consumer Healthcare Drug Product
Table 131. East China Medicine Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 132. East China Medicine Recent Development
Table 133. Livzon Group Company Detail
Table 134. Livzon Group Business Overview
Table 135. Livzon Group Consumer Healthcare Drug Product
Table 136. Livzon Group Revenue in Consumer Healthcare Drug Business (2018-2024) & (US$ Million)
Table 137. Livzon Group Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Consumer Healthcare Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Consumer Healthcare Drug Market Share by Type: 2022 VS 2029
Figure 3. Solid Preparations Features
Figure 4. Oral Liquid Features
Figure 5. Patch Features
Figure 6. Other Features
Figure 7. Global Consumer Healthcare Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Consumer Healthcare Drug Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Consumer Healthcare Drug Report Years Considered
Figure 13. Global Consumer Healthcare Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Consumer Healthcare Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Consumer Healthcare Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Consumer Healthcare Drug Market Share by Players in 2022
Figure 17. Global Top Consumer Healthcare Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Consumer Healthcare Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Consumer Healthcare Drug Revenue in 2022
Figure 19. North America Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Consumer Healthcare Drug Market Share by Country (2018-2029)
Figure 21. United States Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Consumer Healthcare Drug Market Share by Country (2018-2029)
Figure 25. Germany Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Consumer Healthcare Drug Market Share by Region (2018-2029)
Figure 33. China Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Consumer Healthcare Drug Market Share by Country (2018-2029)
Figure 41. Mexico Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Consumer Healthcare Drug Market Share by Country (2018-2029)
Figure 45. Turkey Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Consumer Healthcare Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Johnson & Johnson Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 48. AbbVie Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 49. Merck & Co. Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 51. Pfizer Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 52. Sanofi Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 53. Takeda Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 54. Bayer Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 55. Teva Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 56. Sinopharm Group Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 57. CR Pharmaceutical Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 58. Shanghai Pharmaceuticals Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 59. Hualan Bio Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 60. North China Pharmaceutical Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 61. Hengrui Medicine Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 62. Fosun Pharma Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 63. East China Medicine Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 64. Livzon Group Revenue Growth Rate in Consumer Healthcare Drug Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries